中国与加拿大急性心肌梗死治疗质量分析

Quality of acute myocardial infarction treatment in China and Canada

摘要: 目的了解中国与加拿大急性心肌梗死(AMI)的治疗方式和住院死亡率的差别,为提高中国AMI患者的治疗质量提供依据。方法采用χ²检验对中国与加拿大AMI患者的冠状动脉造影率、介入治疗率和冠状动脉搭桥术率及住院死亡率的差别进行比较。结果中国冠状动脉造影率(68.48%)和冠状动脉搭桥术率(2.3%)均低于加拿大(72.39%,8.7%),差异有统计学意义(P<0.05);介入治疗率(91.68%)和住院死亡率(10.18%)均高于加拿大(56.98%,4.90%),差异有统计学意义(P<0.05)。结论介入治疗在中国已经成为AMI治疗的重要手段,但冠状动脉搭桥术的使用与加拿大相比还存在一定差距。

Abstract: ObjectiveTo understand the differences in acute myocardial infarction(AMI)treatment and hospitalmor-tality between Canada and China.MethodsApplying Chisquare test to compare the differences of cornary angiog raphy (CAG)rate,percutaneous coronary intervention(PCI)rate and hospital mortalitiy bewteen China and Canada.ResultsIn China,the CAG rate(68.48%)and coronary artery bypass graft(CABG)rate(2.3%)were lower than those of in Canada (56.98%,4.9%).But the PCI rate(91.68%)and hospital mortality(10.18%)in China were higher than those of in Canada (56.98%,4.9%).ConclusionThe application of CABG varies in China and in Canada.It is necessary to analyze it deeply.